The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts ; volume:15 ; number:1 ; day:10 ; month:3 ; year:2015 ; pages:1-10 ; date:12.2015
BMC cancer ; 15, Heft 1 (10.3.2015), 1-10, 12.2015
- Urheber
-
Fung, Andrea S.
- Beteiligte Personen und Organisationen
-
Lee, Carol
Yu, Man
Tannock, Ian F.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1091-6
- URN
-
urn:nbn:de:1111-2016110620080
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fung, Andrea S.
- Lee, Carol
- Yu, Man
- Tannock, Ian F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Origin of the vasculature supporting growth of primary patient tumor xenografts
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings
Design Optimization of Tumor Vasculature-Bound Nanoparticles
The tumor vasculature an attractive CAR T cell target in solid tumors
The tumor suppressor SALL2 opposes chemotherapeutic resistance in breast cancer
Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors
Tumor vasculature: a sally port for inhibiting cancer cell spreading
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Origin of the vasculature supporting growth of primary patient tumor xenografts
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings
Design Optimization of Tumor Vasculature-Bound Nanoparticles
The tumor vasculature an attractive CAR T cell target in solid tumors
The tumor suppressor SALL2 opposes chemotherapeutic resistance in breast cancer
Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors
Tumor vasculature: a sally port for inhibiting cancer cell spreading
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Origin of the vasculature supporting growth of primary patient tumor xenografts
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings
Design Optimization of Tumor Vasculature-Bound Nanoparticles
The tumor vasculature an attractive CAR T cell target in solid tumors
The tumor suppressor SALL2 opposes chemotherapeutic resistance in breast cancer
Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors